Chemoinformaics analysis of 15-nor-Funebran-3-one
Molecular Weight | 206.329 | nRot | 0 |
Heavy Atom Molecular Weight | 184.153 | nRig | 14 |
Exact Molecular Weight | 206.167 | nRing | 3 |
Solubility: LogS | -3.729 | nHRing | 0 |
Solubility: LogP | 3.368 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 38.8514 |
nHD | 0 | BPOL | 22.9386 |
QED | 0.593 |
Synth | 5.258 |
Natural Product Likeliness | 3.045 |
NR-PPAR-gamma | 0.053 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.036 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.719 |
MDCK | 0.0000209 |
BBB | 0.932 |
PPB | 0.847242 |
VDSS | 1.18 |
FU | 0.170081 |
CYP1A2-inh | 0.093 |
CYP1A2-sub | 0.381 |
CYP2c19-inh | 0.134 |
CYP2c19-sub | 0.875 |
CYP2c9-inh | 0.323 |
CYP2c9-sub | 0.691 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.833 |
CYP3a4-inh | 0.068 |
CYP3a4-sub | 0.218 |
CL | 15.597 |
T12 | 0.265 |
hERG | 0.007 |
Ames | 0.013 |
ROA | 0.322 |
SkinSen | 0.046 |
Carcinogencity | 0.03 |
EI | 0.611 |
Respiratory | 0.769 |
NR-Aromatase | 0.018 |
Antiviral | Yes |
Prediction | 0.854764 |